Here's what to look for this week on Contemporary OB/GYN®.
This week's topics include:
The advisory panel is also scheduled to discuss Merck antiviral pill late next month.
Using data from SWAN DHS, investigators determined changes in menstrual cycle length prior to a woman's final menstrual period were associated with changes in carotid intima-media thickness and brachial-ankle pulse wave velocity.
A pair of studies provide insight into the increased risk of dysglycemia among women with PCOS and the potential influence of combined oral contraceptive pills on this risk in a population-based cohort.
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More